Quantcast

Latest Metoprolol Stories

2014-03-31 13:41:48

The 6-month follow-up data from the METOCARD-CNIC trial are published today in the Journal of the American College of Cardiology The initial results of this trial were published a few months ago (Circulation. 2013;128:1495-1503), and showed that patients who received this treatment during emergency transit to hospital had much smaller amounts of dead heart muscle than those randomly assigned to receive no treatment. The new study shows that the proportion of patients with a severely...

2013-10-01 23:04:20

Collaborative Study by Spain and Icahn School of Medicine at Mount Sinai Shows Potential Benefits of Administering Beta-Blocker Medication to Heart Attack Patients in Ambulance New York, NY (PRWEB) October 01, 2013 Early treatment of heart attack patients with an inexpensive beta-blocker drug called metoprolol, while in transit to the hospital, can significantly reduce damage to the heart during a myocardial infarction, according to clinical trial study results published Oct. 1 in the...

2010-04-21 07:00:00

SCHAUMBURG, Ill., April 21 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced FDA approval of metoprolol tartrate injection, USP (metoprolol). The AP-rated product will be sold in latex-free 5 mg per 5 mL vials that feature Sagent's proprietary PreventIV Measures(TM) labeling and packaging. Metoprolol is commonly used in the treatment of acute myocardial infarction (AMI). According to the American Heart Association, an estimated...

2010-04-15 15:15:00

MORRISTOWN, N.J., April 15 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), today announced that its subsidiary, Watson Laboratories, Inc. - Florida, has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for metoprolol succinate extended-release tablets USP in the 100 and 200 mg strengths, the generic equivalent to AstraZeneca's Toprol XL® tablets. Watson intends to begin shipping the...

2009-08-03 15:00:00

MORRISTOWN, N.J., Aug. 3 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the United States Food and Drug Administration on its Abbreviated New Drug Applications (ANDAs) for metoprolol succinate extended-release tablets USP in the 25 mg and 50 mg strengths. Metoprolol succinate extended-release tablets are the generic equivalent to...

2009-05-18 08:00:00

WILMINGTON, Del., May 18 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) announced today that all wholesale ordering restrictions in place for TOPROL-XL(R) (metoprolol succinate) extended release tablets have been removed and that supply levels of TOPROL-XL are approaching near usual levels at all points in the distribution chain. AstraZeneca has been diligently working to help ensure adequate market supply of TOPROL-XL and the authorized generic metoprolol succinate following published...

5b023a94987e3b3e30d2afca316e8a551
2008-12-30 08:54:35

Long-term gene therapy resulted in improved cardiac function and reversed deterioration of the heart in rats with heart failure, according to a recent study conducted by researchers at Thomas Jefferson University's Center for Translational Medicine. The study was published online in Circulation. The rats were treated with a gene that generates a peptide called bARKct, which was administered to hearts in combination with recombinant-adeno-associated virus serotype 6 (rAAV6). bARKct works by...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.